Epigral Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 19,291.92 million compared to INR 21,884 million a year ago. Revenue was INR 19,357.07 million compared to INR 21,963.84 million a year ago.

Net income was INR 1,958.16 million compared to INR 3,532.91 million a year ago. Basic earnings per share from continuing operations was INR 47.13 compared to INR 85.03 a year ago. Diluted earnings per share from continuing operations was INR 47.13 compared to INR 85.03 a year ago.